OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced the appointment of John D. Thompson to its Board of Directors. His appointment was effective May 14, 2014. “John Thompson brings extensive experience in life […]
LEXINGTON, Mass.-– N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with OncoDNA, the first company in Europe to provide personalized medicine in oncology based on the molecular analysis of each patient’s tumor. Under this agreement, N-of-One will provide the clinical interpretation for all of OncoDNA’s next-generation sequencing […]
BD MAX™ Enteric Parasite Panel Achieves CE Mark to Detect Common and Pathogenic Intestinal Parasites
Sparks, Maryland -–BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ Enteric Parasite Panel for use with the BD MAX System. The BD MAX Enteric Parasite Panel is the latest panel in the BD MAX Enteric suite for the diagnosis of […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™. The assay will complement Luminex’s growing portfolio of ASR and IVD products. Previously announced items in the five assay launch menu targeted for […]
SISCAPA Assay Technologies, Inc. today announced that it closed a Series A equity financing round aimed at funding the company’s R&D efforts, expanding its catalog of assays, and driving its commercialization activities. The financing was led by the company’s angel investors and included a small number of new, private investors. “Adoption of our technology by […]
BARCELONA, Spain — At the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker introduces new and expanded research-use only (RUO) capabilities for the MALDI Biotyper™ platform. The MALDI Biotyper (MBT) is the market-leading system for microbial identification based on MALDI-TOF mass spectrometry. It is widely used in industrial microbiology, animal health, food […]
SANTA CLARA, Calif. — Affymetrix, Inc. (NASDAQ:AFFX) and Leica Biosystems announce the launch of Affymetrix’ fully automated RNA in situ hybridization assays ViewRNATM eZ Assays on the Leica BOND RX staining platform. These assays detect coding RNA as well as novel non-coding markers in formalin-fixed paraffin-embedded (FFPE) tissues. Dedicated for research use only*, the assays […]
HealthCare Global (HCG) Enterprises Ltd, The Specialists in Cancer Care, creates a new benchmark in cancer care by making genomics-based diagnostics, a ‘standard-of-care’ for cancer treatment in India. These diagnostic tests will support physicians, and their patients with the most accurate and advanced tumor profiling of large number genes for “actionable” mutations. The information about […]
Sparks, Maryland — BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX™ Enteric Bacterial Panel for use on the BD MAX System. The BD MAX Enteric Bacterial Panel is a qualitative IVD test detecting DNA from Campylobacter spp. […]
OAKLAND, Calif.– Omicia, Inc., the leading genome interpretation company, today announced the appointment of Paul Billings, MD, PhD, FACP, FACMG as Chief Medical Officer (CMO) and will serve on Omicia’s Scientific Advisory Board. Dr. Billings joins Omicia as genomics expands from the research lab to become a valuable clinical diagnostic tool. He joins Omicia’s leadership […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
